ABO blood group is a predictor of survival in patients undergoing surgery for renal cell carcinoma

scientific article published on 07 September 2012

ABO blood group is a predictor of survival in patients undergoing surgery for renal cell carcinoma is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1111/J.1464-410X.2012.11366.X
P698PubMed publication ID22958439

P50authorSamuel D KaffenbergerQ84947422
Sam S. ChangQ91553580
P2093author name stringDaniel A Barocas
Todd M Morgan
Peter E Clark
S Duke Herrell
Joseph A Smith
Kelly L Stratton
Michael S Cookson
Adu M Boachie
P433issue11 Pt B
P921main subjectrenal cell carcinomaQ1164529
P304page(s)E641-6
P577publication date2012-09-07
P1433published inBJU InternationalQ4835773
P1476titleABO blood group is a predictor of survival in patients undergoing surgery for renal cell carcinoma
P478volume110

Reverse relations

cites work (P2860)
Q53175926AB0 blood groups and rhesus factor expression as prognostic parameters in patients with epithelial ovarian cancer - a retrospective multi-centre study.
Q90338373ABO Blood Type and the Long-term Outcomes of Pancreatic Cancer
Q37336826ABO blood group is a predictor of survival in patients with laryngeal cancer
Q64966406ABO blood group polymorphism has an impact on prostate, kidney and bladder cancer in association with longevity.
Q33861119ABO blood type correlates with survival in hepatocellular carcinoma following hepatectomy
Q27001058Antibodies: At The Nexus of Antigens and Cancer Vaccines
Q41550593Association between ABO blood types and sporadic pancreatic neuroendocrine tumors in the Chinese Han population
Q39780523Associations between ABO blood groups and biochemical recurrence after radical prostatectomy
Q47133170Blood type AB predicts promising prognosis in gastric cancer patients with positive preoperative serum CEA.
Q51150690Do blood groups have effect on prognosis of patients undergoing radical cystectomy?
Q40156303Effect of ABO blood type on the outcomes of patients with metastatic renal cell carcinoma treated with first-line tyrosine kinase inhibitors.
Q57463196Evaluation of ABO blood groups and blood-based biomarkers as a predictor of growth kinetics of renal angiomyolipoma
Q38162755Hemostasis, cancer, and ABO blood group: the most recent evidence of association
Q35792913Impact of ABO blood group on the prognosis of patients undergoing surgery for esophageal cancer
Q54729569Non-O blood type is associated with an increased risk of venous thromboembolism after radical cystectomy.
Q64237813O Blood Type Is Associated with Unfavorable Distant-metastasis-free Survival in Female Patients with Nasopharyngeal Carcinoma: A Retrospective Study of 2439 Patients from Epidemic Area
Q37391865Prognostic role of pretreatment serum albumin in renal cell carcinoma: a systematic review and meta-analysis
Q36121231Prognostic role of the ABO blood types in Chinese patients with curatively resected non-small cell lung cancer: a retrospective analysis of 1601 cases at a single cancer center
Q41041253Prognostic value of ABO blood group in patients with early stage cervical cancer treated with radical hysterectomy with pelvic node dissection
Q38357713Prognostic value of ABO blood group in patients with renal cell carcinoma: single-institution results from a large cohort
Q37279227Prognostic value of ABO blood group in southern Chinese patients with established nasopharyngeal carcinoma
Q92838818Serum CEA level lost its prognostic value in gastric cancer patients with AB blood type
Q34757109Statin use is associated with improved survival in patients undergoing surgery for renal cell carcinoma
Q35028168The ABO blood group is an independent prognostic factor in patients with resected non-small cell lung cancer
Q39202716The ABO blood group predicts survival in esophageal squamous cell carcinoma in patients who ever smoked: a retrospective study from China
Q41432872The association of ABO blood type with disease recurrence and mortality among patients with urothelial carcinoma of the bladder undergoing radical cystectomy
Q53574858The impact of the AB0 and the Rhesus blood group system on outcomes in bladder cancer patients treated with radical cystectomy.
Q26775411The prognostic value of ABO blood group in cancer patients
Q53185271Timing of blood transfusion and not ABO blood type is associated with survival in patients treated with radical cystectomy for nonmetastatic bladder cancer: Results from a single high-volume institution.

Search more.